ArticleFrontiers in oncology2022

Global research trends on anti-PD-1/anti-PD-L1 immunotherapy for triple-negative breast cancer: A scientometric analysis.

Jinyao Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.